相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides
Hannah R. Bridges et al.
SCIENCE (2023)
Rewired Cellular Metabolic Profiles in Response to Metformin under Different Oxygen and Nutrient Conditions
Shan Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: results from the SPIRIT randomized trial
Curtis Tilves et al.
INTERNATIONAL JOURNAL OF OBESITY (2022)
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives
Federica Barbieri et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
Teng Ma et al.
NATURE (2022)
A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1)
Marijo Bilusic et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2022)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Metformin promotes histone deacetylation of optineurin and suppresses tumour growth through autophagy inhibition in ocular melanoma
Ai Zhuang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer The MA.32 Randomized Clinical Trial
Pamela J. Goodwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Intestinal AMPK modulation of microbiota mediates crosstalk with brown fat to control thermogenesis
Eryun Zhang et al.
NATURE COMMUNICATIONS (2022)
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
McKenzie Crist et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Impact of Concomitant Medications on Biochemical Outcome in Localised Prostate Cancer Treated with Radiotherapy and Androgen Deprivation Therapy
S. Roy et al.
CLINICAL ONCOLOGY (2021)
Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer
Hanyu Chen et al.
GUT (2021)
The Effect of Metformin in Treatment of Adenomas in Patients with Familial Adenomatous Polyposis
Jae Jun Park et al.
CANCER PREVENTION RESEARCH (2021)
Mechanisms of action of metformin and its regulatory effect on microRNAs related to angiogenesis
Gang Wang et al.
PHARMACOLOGICAL RESEARCH (2021)
Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas
Pooja Panwalkar et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors
Jamaji C. Nwanaji-Enwerem et al.
CLINICAL EPIGENETICS (2021)
Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial
Noel T. Mueller et al.
DIABETES CARE (2021)
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial
Monika Janda et al.
GYNECOLOGIC ONCOLOGY (2021)
Effects of Metformin on the virus/host cell crosstalk in human papillomavirus-positive cancer cells
Karin Hoppe-Seyler et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Mitochondrial complex I inhibitors suppress tumor growth through concomitant acidification of the intra- and extracellular environment
Junjiro Yoshida et al.
ISCIENCE (2021)
A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density
Edgar Tapia et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Metformin: review of epidemiology and mechanisms of action in pancreatic cancer
Guido Eibl et al.
CANCER AND METASTASIS REVIEWS (2021)
TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer
Marc Pujalte Martin et al.
CLINICAL GENITOURINARY CANCER (2021)
Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer
Jingjing Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
PD-L1 degradation is regulated by electrostatic membrane association of its cytoplasmic domain
Maorong Wen et al.
NATURE COMMUNICATIONS (2021)
Effects of a Behavioral Weight Loss Intervention and Metformin Treatment on Serum Urate: Results from a Randomized Clinical Trial
Jiun-Ruey Hu et al.
NUTRIENTS (2021)
Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer The NRG-LU001 Phase 2 Randomized Clinical Trial
Heath Skinner et al.
JAMA ONCOLOGY (2021)
Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects
Ratna Veeramachaneni et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer
Andrea Rocca et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)
Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer
Shuchi Gulati et al.
CANCER (2020)
Metformin Effects on FOXP3+and CD8+T Cell Infiltrates of Head and Neck Squamous Cell Carcinoma
Dev Amin et al.
LARYNGOSCOPE (2020)
Metformin plus megestrol acetate compared with MA alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial
B-Y Yang et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin
Simon R. Lord et al.
BRITISH JOURNAL OF CANCER (2020)
A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index
Jason A. Zell et al.
CANCER PREVENTION RESEARCH (2020)
Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis
Dan Jin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial
Alessandra Gennari et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate
Jianjiang Xie et al.
CANCER RESEARCH (2020)
Metformin activates AMPK/SIRT1/NF-κB pathway and induces mitochondrial dysfunction to drive caspase3/GSDME-mediated cancer cell pyroptosis
Zhaodi Zheng et al.
CELL CYCLE (2020)
Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway
Ruijie Sun et al.
CANCER MEDICINE (2020)
Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers
Nicholas W. Bateman et al.
CANCER MEDICINE (2020)
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
K. Esther Broekman et al.
INVESTIGATIONAL NEW DRUGS (2020)
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma
Katherine M. Bever et al.
Oncotarget (2020)
SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways
Huairui Yuan et al.
CANCER CELL (2020)
Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin
Ramy Ayoub et al.
NATURE MEDICINE (2020)
Synthetic Lethal Metabolic Targeting of Androgen-Deprived Prostate Cancer Cells with Metformin
Bing Yang et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis
Xiaowen Huang et al.
EBIOMEDICINE (2020)
Metformin as a senostatic drug enhances the anticancer efficacy of CDK4/6 inhibitor in head and neck squamous cell carcinoma
Qinchao Hu et al.
CELL DEATH & DISEASE (2020)
Metformin induces cell cycle arrest, apoptosis and autophagy through ROS/JNK signaling pathway in human osteosarcoma
Bo Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study
John W. Apolzan et al.
ANNALS OF INTERNAL MEDICINE (2019)
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis
Mohamed Elgendy et al.
CANCER CELL (2019)
Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis
Lu Wang et al.
CANCER LETTERS (2019)
The mystery of metformin
Martin J. Spiering
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells
Xiteng Yin et al.
CELLULAR ONCOLOGY (2019)
Metformin and 4SC-202 synergistically promote intrinsic cell apoptosis by accelerating ΔNp63 ubiquitination and degradation in oral squamous cell carcinoma
Yuan He et al.
CANCER MEDICINE (2019)
Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
Ji-Chang Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Antitumour effects of metformin and curcumin in human papillomavirus positive and negative head and neck cancer cells
Cameron Lindsay et al.
MOLECULAR CARCINOGENESIS (2019)
Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity
Tien S. Dong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)
Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer
Ji-Hye Park et al.
CANCER SCIENCE (2019)
Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy
Rosina Pryor et al.
CELL (2019)
Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial
Li Li et al.
CLINICAL CANCER RESEARCH (2019)
Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells
Yanju Wu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
A phase I delayed-start, randomized and pharmacodynamic study of metformin and chemotherapy in patients with solid tumors
Mohammad Wasif Saif et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy
Bin Zhao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study
Michael Mark et al.
CLINICAL GENITOURINARY CANCER (2019)
A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy
Isabel Pimentel et al.
BREAST (2019)
Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish
Sofia de Oliveira et al.
JOURNAL OF HEPATOLOGY (2019)
Metformin and glucose starvation decrease the migratory ability of hepatocellular carcinoma cells: targeting AMPK activation to control migration
Anabela C. Ferretti et al.
SCIENTIFIC REPORTS (2019)
High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells
Sharon Varghese et al.
BIOMOLECULES (2019)
Bioactivity and prostate tissue distribution of metformin in a preprostatectomy prostate cancer cohort
Mike M. Nguyen et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2018)
Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism
E. Cuyas et al.
ONCOGENE (2018)
Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
Elisabet Cuyas et al.
AGING CELL (2018)
Metformin reduces TRIB3 expression and restores autophagy flux: an alternative antitumor action
Ke Li et al.
AUTOPHAGY (2018)
Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway
Paige V. Bauer et al.
CELL METABOLISM (2018)
Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration
Qiuli Liu et al.
CLINICAL CANCER RESEARCH (2018)
Metformin in cancer
Ritwika Mallik et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways
Yan Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function
Lixin Wan et al.
MOLECULAR CELL (2018)
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
Simon R. Lord et al.
CELL METABOLISM (2018)
Effect of metformin on the survival of patients with ALL who express high levels of the ABCB1 drug resistance gene
Christian Ramos-Penafiel et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
Jong-Ho Cha et al.
MOLECULAR CELL (2018)
Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer
Di Wu et al.
NATURE (2018)
Metformin as an Anticancer Agent
Ales Vancura et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability
Federica Barbieri et al.
FRONTIERS IN PHARMACOLOGY (2018)
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Lulu Sun et al.
NATURE MEDICINE (2018)
Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD plus Depletion in Cancer Cells
Don Benjamin et al.
CELL REPORTS (2018)
Renoprotective Effects of Metformin
Marc E. De Broe et al.
NEPHRON (2018)
Metformin alters DNA methylation genome-wide via the H19/SAHH axis
T. Zhong et al.
ONCOGENE (2017)
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
Nicole E. Scharping et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Metformin targets gastric cancer stem cells
Sarah Courtois et al.
EUROPEAN JOURNAL OF CANCER (2017)
Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system
Jie Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation (vol 46, pg 728, 2017
Ruth E. Farmer et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Metformin Effects on Head and Neck Squamous Carcinoma Microenvironment: Window of Opportunity Trial
Joseph Curry et al.
LARYNGOSCOPE (2017)
Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells
Wei Xie et al.
MEDICAL SCIENCE MONITOR (2017)
Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities
Claudio Pulito et al.
CELL DISCOVERY (2017)
Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production
Angela Mogavero et al.
SCIENTIFIC REPORTS (2017)
Negative regulation of Sirtuin 1 by AMP-activated protein kinase promotes metformin-induced senescence in hepatocellular carcinoma xenografts
Xinke Zhou et al.
CANCER LETTERS (2017)
Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis
Jared M. Campbell et al.
AGEING RESEARCH REVIEWS (2017)
Repurposing metformin for the prevention of cancer and cancer recurrence
Brandy M. Heckman-Stoddard et al.
DIABETOLOGIA (2017)
Epithelial Gpr116 regulates pulmonary alveolar homeostasis via Gq/11 signaling
Kari Brown et al.
JCI INSIGHT (2017)
Chloride intracellular channel 1 regulates the antineoplastic effects of metformin in gallbladder cancer cells
Yongchen Liu et al.
CANCER SCIENCE (2017)
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
C. Coyle et al.
ANNALS OF ONCOLOGY (2016)
Metabolic Control of Longevity
Carlos Lopez-Otin et al.
CELL (2016)
An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer
Lianfeng Wu et al.
CELL (2016)
Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation
Silvia Peppicelli et al.
CELL CYCLE (2016)
Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival
Maike Zimmermann et al.
CELL CYCLE (2016)
Environment Dictates Dependence on Mitochondrial Complex I for NAD plus and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin
Dan Y. Gui et al.
Cell Metabolism (2016)
Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study
Pamela T. Soliman et al.
GYNECOLOGIC ONCOLOGY (2016)
Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy
Gadi Shlomai et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
Metformin: An anti-diabetic drug to fight cancer
Marie Daugan et al.
PHARMACOLOGICAL RESEARCH (2016)
Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy
Krista C. J. Wink et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Metabolic control of epigenetics in cancer
Adam Kinnaird et al.
NATURE REVIEWS CANCER (2016)
p53 is required for metformin-induced growth inhibition, senescence and apoptosis in breast cancer cells
Puyu Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models
Fu-Ming Zi et al.
CANCER LETTERS (2015)
Metformin Does Not Reduce Markers of Cell Proliferation in Esophageal Tissues of Patients With Barrett's Esophagus
Amitabh Chak et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms
Vincenza Cifarelli et al.
DIABETES (2015)
NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin
Dong Suwei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Effect of Metformin vs Placebo on Weight and Metabolic Factors in NCIC CTG MA.32
Pamela J. Goodwin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Sil Kordes et al.
LANCET ONCOLOGY (2015)
Metformin and cancer: Between the bioenergetic disturbances and the antifolate activity
J. A. Jara et al.
PHARMACOLOGICAL RESEARCH (2015)
Immune-mediated antitumor effect by type 2 diabetes drug, metformin
Shingo Eikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer
Lacey M. Litchfield et al.
ONCOTARGET (2015)
Effect of Metformin vs Placebo on Weight and Metabolic Factors in NCIC CTG MA.32
Pamela J. Goodwin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas
Maria Ignez Braghiroli et al.
ECANCERMEDICALSCIENCE (2015)
Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study
Ryan J. O. Dowling et al.
BREAST CANCER RESEARCH (2015)
Metformin in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Phase 2 Trial (SAKK 08/09)
Christian Rothermundt et al.
EUROPEAN UROLOGY (2014)
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo
Hisaaki Miyoshi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Metformin-mode of action and clinical implications for diabetes and cancer
Ida Pernicova et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Cellular senescence: from physiology to pathology
Daniel Munoz-Espin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells
Andreas Janzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
Y. Feng et al.
CELL DEATH & DISEASE (2014)
Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1-and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells
M. A. Babcook et al.
CELL DEATH & DISEASE (2014)
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
William W. Wheaton et al.
ELIFE (2014)
Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
Sarah-Maria Fendt et al.
CANCER RESEARCH (2013)
Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines
Floriana Morgillo et al.
CLINICAL CANCER RESEARCH (2013)
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Hsiao-Ping Chen et al.
GUT (2013)
Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway
Gao Yi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy
David A. Iglesias et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
M. A. Pierotti et al.
ONCOGENE (2013)
Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
Arian Emami Riedmaier et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
Bin Bao et al.
CANCER PREVENTION RESEARCH (2012)
Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage
Carolyn Algire et al.
CANCER PREVENTION RESEARCH (2012)
Metformin lowers the threshold for stress-induced senescence A role for the microRNA-200 family and miR-205
Silvia Cufi et al.
CELL CYCLE (2012)
Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation
Arron Sikka et al.
CELL CYCLE (2012)
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
R. J. Stevens et al.
DIABETOLOGIA (2012)
Metformin Inhibits Growth of Thyroid Carcinoma Cells, Suppresses Self-Renewal of Derived Cancer Stem Cells, and Potentiates the Effect of Chemotherapeutic Agents
Guofang Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Metformin in cancer: translational challenges
Ryan J. O. Dowling et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo
Kiyohito Kato et al.
MOLECULAR CANCER THERAPEUTICS (2012)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
Chang W. Song et al.
SCIENTIFIC REPORTS (2012)
Metformin in prostate cancer: two for the price of one
A. Clements et al.
ANNALS OF ONCOLOGY (2011)
Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
Dimitrios Iliopoulos et al.
CANCER RESEARCH (2011)
Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ Visualizing the therapeutic effects of metformin in tumor tissue
Diana Whitaker-Menezes et al.
CELL CYCLE (2011)
Clinical Pharmacokinetics of Metformin
Garry G. Graham et al.
CLINICAL PHARMACOKINETICS (2011)
In vitro and in vivo anti-melanoma action of metformin
Kristina Janjetovic et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Diabetes and Cancer: A Consensus Report
Edward Giovannucci et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
Irina N. Alimova et al.
CELL CYCLE (2009)
Chronic inflammation, the tumor microenvironment and carcinogenesis
Tamas A. Gonda et al.
CELL CYCLE (2009)
IGF and Insulin Receptor Signaling in Breast Cancer
Antonino Belfiore et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production
Eric L. Bell et al.
JOURNAL OF CELL BIOLOGY (2007)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro
Milica Momcilovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Ca2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells
A Woods et al.
CELL METABOLISM (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
A Woods et al.
CURRENT BIOLOGY (2003)
Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling
XS Gao et al.
NATURE CELL BIOLOGY (2002)
The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism
SA Hawley et al.
DIABETES (2002)
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
DC Fingar et al.
GENES & DEVELOPMENT (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Metformin in non-alcoholic steatohepatitis
G Marchesini et al.
LANCET (2001)
Role for a bidentate ribonuclease in the initiation step of RNA interference
E Bernstein et al.
NATURE (2001)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
